Literature DB >> 24227972

Successful treatment of melanocytoma associated choroidal neovascular membrane with intravitreal bevacizumab.

Ali M Al-Halafi1.   

Abstract

Melanocytoma of the optic disc is a benign melanocytic tumour that rarely causes visual impairment. We report a rare case of choroidal neovascularization (CNV) in association with optic disc melanocytoma and its response to intravitreal injection of the anti-vascular endothelial growth factor (VEGF), bevacizumab. The choroidal neovascular membrane regressed following a single intravitreal bevacizumab injection with formation of a scar. CNV associated with optic disc melanocytoma is rare. Intravitreal anti-VEGF treatment may be an effective treatment for CNV associated with optic disc melanocytoma.

Entities:  

Keywords:  Anti-VEGF; Bevacizumab; Choroidal neovascular membrane; Melanocytoma; Optic disc

Year:  2013        PMID: 24227972      PMCID: PMC3809465          DOI: 10.1016/j.sjopt.2012.12.002

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  8 in total

1.  Choroidal neovascularization of optic disk melanocytoma treated with bevacizumab.

Authors:  Taro Kamisasanuk; Eisuke Uchino; Taiji Sakamoto
Journal:  Eur J Ophthalmol       Date:  2012 May-Jun       Impact factor: 2.597

2.  Choroidal neovascular membrane associated with melanocytoma of the optic nerve.

Authors:  K V Chalam; Gaurav Y Shah; Vinay A Shah; Kenneth D Rappaport
Journal:  Retina       Date:  2006 Jul-Aug       Impact factor: 4.256

3.  Disciform lesion overlying melanocytoma simulating progression of choroidal melanoma.

Authors:  M L Rubin
Journal:  Trans Am Ophthalmol Soc       Date:  1976

4.  Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Authors:  Robert L Avery; Dante J Pieramici; Melvin D Rabena; Alessandro A Castellarin; Ma'an A Nasir; Matthew J Giust
Journal:  Ophthalmology       Date:  2006-02-03       Impact factor: 12.079

5.  Clinical and follow-up studies of melanocytomas of the optic disc.

Authors:  L Joffe; J A Shields; R H Osher; J D Gass
Journal:  Ophthalmology       Date:  1979-06       Impact factor: 12.079

6.  Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

Authors:  Wai-Man Chan; Timothy Y Y Lai; David T L Liu; Dennis S C Lam
Journal:  Am J Ophthalmol       Date:  2007-04-24       Impact factor: 5.258

7.  Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; David T L Liu; Dennis S C Lam
Journal:  Ophthalmology       Date:  2007-06-28       Impact factor: 12.079

8.  Peripapillary choroidal neovascularization associated with melanocytoma of the optic disc: a clinicopathologic case report.

Authors:  H Viet Tran; Etienne H Bovey; Sylvie Uffer; Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

  8 in total
  2 in total

1.  Bevacizumab for the treatment of a complicated posterior melanocytoma.

Authors:  Julio A Urrets-Zavalia; Nicolas Crim; Evangelina Esposito; Leandro Correa; M Eugenia Gonzalez-Castellanos; Dana Martinez
Journal:  Clin Ophthalmol       Date:  2015-03-06

2.  Management of Choroidal Neovascularization Associated with Optic Disc Melanocytoma with Intravitreal Aflibercept: A Case Report and Review of the Literature.

Authors:  Hany S Hamza; Magdy Moussa; Abdelrahman M Elhusseiny
Journal:  Case Rep Ophthalmol Med       Date:  2019-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.